BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Ecopia

About Celera

Ecopia is advancing its drug candidate ECO-4601, a potential new treatment for brain cancer, through preclinical trials and expects to file an IND in 2005. Using its innovative DECIPHER® technology, the Company employs a radically different approach to discover new drugs, with anticancer, antibacterial or antifungal activity, from bacteria called actinomycetes.

Ecopia's discovery activities center on compounds produced naturally by bacteria known as the Actinomycetes.

 

PRODUCT PIPELINE

TECHNOLOGY

 

More on Ecopia

Home Page

Chart on Ecopia

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com